All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-ZP312 | Human anti-Insulin-2 T cell receptor (20.D11), pCDTCR1 | Mouse | 20.D11 | Human | SHLVEALYLVCGERG | HLA-DQ8 | Lentiviral vector | |
TCR-ZP313 | Human anti-Insulin-2 T cell receptor (6.H9), pCDTCR1 | Mouse | 6.H9 | Human | SHLVEALYLVCGERG | HLA-DQ8 | Lentiviral vector | |
TCR-ZP314 | anti-Insulin-2 T cell receptor (BDC12-4.1), pCDTCR1 | Mouse | BDC12-4.1 | SHLVEALYLVCGERG | HLA-DQ8 | Lentiviral vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION